1ao4
From Proteopedia
| Line 1: | Line 1: | ||
[[Image:1ao4.gif|left|200px]] | [[Image:1ao4.gif|left|200px]] | ||
| - | + | <!-- | |
| - | + | The line below this paragraph, containing "STRUCTURE_1ao4", creates the "Structure Box" on the page. | |
| - | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
| - | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
| - | | | + | or leave the SCENE parameter empty for the default display. |
| - | | | + | --> |
| - | + | {{STRUCTURE_1ao4| PDB=1ao4 | SCENE= }} | |
| - | + | ||
| - | + | ||
| - | }} | + | |
'''COBALT(III)-PEPLOMYCIN COMPLEX DETERMINED BY NMR STUDIES''' | '''COBALT(III)-PEPLOMYCIN COMPLEX DETERMINED BY NMR STUDIES''' | ||
| Line 19: | Line 16: | ||
==About this Structure== | ==About this Structure== | ||
| - | + | Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1AO4 OCA]. | |
==Reference== | ==Reference== | ||
Structures of cobalt(III)-pepleomycin and cobalt(III)-deglycopepleomycin (green forms) determined by NMR studies., Caceres-Cortes J, Sugiyama H, Ikudome K, Saito I, Wang AH, Eur J Biochem. 1997 Mar 15;244(3):818-28. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/9108252 9108252] | Structures of cobalt(III)-pepleomycin and cobalt(III)-deglycopepleomycin (green forms) determined by NMR studies., Caceres-Cortes J, Sugiyama H, Ikudome K, Saito I, Wang AH, Eur J Biochem. 1997 Mar 15;244(3):818-28. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/9108252 9108252] | ||
| - | [[Category: Protein complex]] | ||
[[Category: Caceres-Cortes, J.]] | [[Category: Caceres-Cortes, J.]] | ||
[[Category: Ikudome, K.]] | [[Category: Ikudome, K.]] | ||
| Line 29: | Line 25: | ||
[[Category: Sugiyama, H.]] | [[Category: Sugiyama, H.]] | ||
[[Category: Wang, A H.J.]] | [[Category: Wang, A H.J.]] | ||
| - | [[Category: | + | [[Category: Anticancer drug]] |
| - | [[Category: | + | [[Category: Bleomycin]] |
| - | [[Category: | + | [[Category: Dna]] |
| - | [[Category: | + | [[Category: Pepleomycin]] |
| - | [[Category: | + | [[Category: Peplomycin]] |
| - | [[Category: | + | [[Category: Solution structure]] |
| - | [[Category: | + | [[Category: Two-dimensional nmr]] |
| - | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 10:29:58 2008'' | |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | |
Revision as of 07:30, 2 May 2008
COBALT(III)-PEPLOMYCIN COMPLEX DETERMINED BY NMR STUDIES
Overview
Pepleomycin (PEP) is a metalloglycopeptide that has stronger anticancer activity and less pulmonary toxicity than bleomycin (BLM). PEP, like BLM, exerts its action by binding to and degrading DNA in the presence of oxygen and certain metals. Obtaining detailed structural information of PEP and PEP-DNA complexes is crucial to understanding its anticancer activity. The structures of two green forms of cobalt-PEP species, HO2-Co(III)-PEP (denoted CoPEP) and deglycosylated HO2-Co(III)-PEP (denoted CodPEP) have been obtained by NOE restrained refinements. Earlier studies of the related HO2-Co(III)-BLM A2 proposed that two chiral conformers (form A or B) could exist with either the beta-aminoalanine primary amine (A,NH2) or the mannose carbamoyl nitrogen (M,NH2) as the axial ligand. Analysis of our NOESY data shows convincingly that form A is the most probable conformer with the mannose carbamoyl M,NH2 and the beta-aminoalanine primary amine A,NH2 as the axial ligands in CoPEP and CodPEP, respectively. The NOE cross-peaks resulting from the interactions between the N-terminus (i.e., the metal-binding domain) and the C-terminus of CoPEP and CodPEP have similar patterns, suggesting that they both adopt compact structures with the bithiazole group folded back over the N-terminus.
About this Structure
Full crystallographic information is available from OCA.
Reference
Structures of cobalt(III)-pepleomycin and cobalt(III)-deglycopepleomycin (green forms) determined by NMR studies., Caceres-Cortes J, Sugiyama H, Ikudome K, Saito I, Wang AH, Eur J Biochem. 1997 Mar 15;244(3):818-28. PMID:9108252 Page seeded by OCA on Fri May 2 10:29:58 2008
